Back to Results
First PageMeta Content
Biotechnology / Abatacept / Bristol-Myers Squibb / Clinical trial / Biologic / Etanercept / Immunosuppressants / Pharmacology / Medicine


BRIEFING DOCUMENT FOR ABATACEPT (BMS[removed]BIOLOGICAL LICENSE APPLICATION[removed]
Add to Reading List

Document Date: 2005-09-02 09:07:06

Open Document

File Size: 1,35 MB

Share Result on Facebook

City

Princeton / /

Company

Bristol-Myers Squibb Company / Any Therapy Group / ACR 20 Subgroup / /

Event

FDA Phase / Product Issues / /

MedicalCondition

Lung Cancer / Patients Reporting Lung Cancer / Lymphoma / Bacterial Infections / Neoplasm AEs / Infections / Patients Reporting Lymphoma / Infection SAEs / Malignant Neoplasms / Lung Cancers / Low Disease / Disorders / /

MedicalTreatment

Biologic Therapy / /

Organization

FOOD AND DRUG ADMINISTRATION ARTHRITIS ADVISORY COMMITTEE / /

Position

General / /

Product

DS / IM101102 / BMS-188667 / RA Patients / Response / Abatacept / /

ProvinceOrState

New Jersey / /

PublishedMedium

Baseline / /

Technology

Antibodies / /

SocialTag